Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions

Table of Contents

January 1, 2016; Volume 60,Issue 1

Challenging Clinical Cases in Antimicrobial Resistance

  • Free
    Challenging Clinical Case in Antimicrobial Resistance
    Clinafloxacin for Treatment of Burkholderia cenocepacia Infection in a Cystic Fibrosis Patient
    Akshu Balwan, David P. Nicolau, Minkey Wungwattana, Jonathan B. Zuckerman, Valerie Waters

Chemistry; Biosynthesis

  • Chemistry; Biosynthesis
    Synthesis, Bioactivity Evaluation, and Toxicity Assessment of Novel Salicylanilide Ester Derivatives as Cercaricides against Schistosoma japonicum and Molluscicides against Oncomelania hupensis
    Weisi Wang, Zhiqiang Qin, Dan Zhu, Yufen Wei, Shizhu Li, Liping Duan

Mechanisms of Action: Physiological Effects

  • Mechanisms of Action: Physiological Effects
    Impact of a Cross-Kingdom Signaling Molecule of Candida albicans on Acinetobacter baumannii Physiology
    Xenia Kostoulias, Gerald L. Murray, Gustavo M. Cerqueira, Jason B. Kong, Farkad Bantun, Eleftherios Mylonakis, Chen Ai Khoo, Anton Y. Peleg
  • Mechanisms of Action: Physiological Effects
    Gallium Potentiates the Antibacterial Effect of Gentamicin against Francisella tularensis
    Helena Lindgren, Anders Sjöstedt
  • Mechanisms of Action: Physiological Effects
    Cardiac Effects of Echinocandins in Endotoxemic Rats
    Christian Koch, Matthias Wolff, Michael Henrich, Markus A. Weigand, Christoph Lichtenstern, Florian Uhle
  • Mechanisms of Action: Physiological Effects
    Penicillin Binding Protein 1 Is Important in the Compensatory Response of Staphylococcus aureus to Daptomycin-Induced Membrane Damage and Is a Potential Target for β-Lactam–Daptomycin Synergy
    Andrew D. Berti, Erin Theisen, John-Demian Sauer, Poochit Nonejuie, Joshua Olson, Joseph Pogliano, George Sakoulas, Victor Nizet, Richard A. Proctor, Warren E. Rose
  • Mechanisms of Action: Physiological Effects
    Interactions of OP0595, a Novel Triple-Action Diazabicyclooctane, with β-Lactams against OP0595-Resistant Enterobacteriaceae Mutants
    David M. Livermore, Marina Warner, Shazad Mushtaq, Neil Woodford

Mechanisms of Resistance

  • Mechanisms of Resistance
    Cooccurrence of Multiple AmpC β-Lactamases in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis in Tunisia
    Thouraya Chérif, Mabrouka Saidani, Dominique Decré, Ilhem Boutiba-Ben Boubaker, Guillaume Arlet
  • Mechanisms of Resistance
    Active-Site Plasticity Is Essential to Carbapenem Hydrolysis by OXA-58 Class D β-Lactamase of Acinetobacter baumannii
    Shivendra Pratap, Madhusudhanarao Katiki, Preet Gill, Pravindra Kumar, Dasantila Golemi-Kotra
  • Mechanisms of Resistance
    Genomic Characteristics of NDM-Producing Enterobacteriaceae Isolates in Australia and Their blaNDM Genetic Contexts
    Alexander M. Wailan, David L. Paterson, Karina Kennedy, Paul R. Ingram, Evan Bursle, Hanna E. Sidjabat
  • Open Access
    Mechanisms of Resistance
    Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers
    Jürgen Brem, Sander S. van Berkel, David Zollman, Sook Y. Lee, Opher Gileadi, Peter J. McHugh, Timothy R. Walsh, Michael A. McDonough, Christopher J. Schofield
  • Mechanisms of Resistance
    The Soil Microbiota Harbors a Diversity of Carbapenem-Hydrolyzing β-Lactamases of Potential Clinical Relevance
    Dereje Dadi Gudeta, Valeria Bortolaia, Greg Amos, Elizabeth M. H. Wellington, Kristian K. Brandt, Laurent Poirel, Jesper Boye Nielsen, Henrik Westh, Luca Guardabassi
  • Mechanisms of Resistance
    Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations
    Hervé Dupont, Olivier Gaillot, Anne-Sophie Goetgheluck, Claire Plassart, Jean-Philippe Emond, Marion Lecuru, Nicolas Gaillard, Sarah Derdouri, Baptiste Lemaire, Marion Girard de Courtilles, Vincent Cattoir, Hedi Mammeri
  • Mechanisms of Resistance
    Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms
    Dominique Sanglard, Alix T. Coste
  • Mechanisms of Resistance
    Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine
    Suci Nuralitha, Josephine E. Siregar, Din Syafruddin, Jessica Roelands, Jan Verhoef, Andy I. M. Hoepelman, Sangkot Marzuki
  • Mechanisms of Resistance
    Role of Non-Active-Site Residue Trp-93 in the Function and Stability of New Delhi Metallo-β-Lactamase 1
    Asad U. Khan, M. Tabish Rehman
  • Open Access
    Mechanisms of Resistance
    Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility
    Zuleima Pava, Irene Handayuni, Grennady Wirjanata, Sheren To, Leily Trianty, Rintis Noviyanti, Jeanne Rini Poespoprodjo, Sarah Auburn, Ric N. Price, Jutta Marfurt
  • Mechanisms of Resistance
    In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates
    Dan Zhang, Yufeng Wang, Jie Lu, Yu Pang
  • Mechanisms of Resistance
    Reactive Oxygen Species Contribute to the Bactericidal Effects of the Fluoroquinolone Moxifloxacin in Streptococcus pneumoniae
    M. J. Ferrándiz, A. J. Martín-Galiano, C. Arnanz, T. Zimmerman, A. G. de la Campa
  • Mechanisms of Resistance
    Carriage of Enterobacteria Producing Extended-Spectrum β-Lactamases and Composition of the Gut Microbiota in an Amerindian Community
    María José Gosalbes, Jorge F. Vázquez-Castellanos, Cécile Angebault, Paul-Louis Woerther, Etienne Ruppé, María Loreto Ferrús, Amparo Latorre, Antoine Andremont, Andrés Moya
  • Mechanisms of Resistance
    Plasmid-Mediated OqxAB Is an Important Mechanism for Nitrofurantoin Resistance in Escherichia coli
    Pak-Leung Ho, Ka-Ying Ng, Wai-U Lo, Pierra Y. Law, Eileen Ling-Yi Lai, Ya Wang, Kin-Hung Chow
  • Mechanisms of Resistance
    Extracellular DNA Acidifies Biofilms and Induces Aminoglycoside Resistance in Pseudomonas aeruginosa
    Mike Wilton, Laetitia Charron-Mazenod, Richard Moore, Shawn Lewenza
  • Mechanisms of Resistance
    Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria
    Ji-Young Lee, Myung-Jin Choi, Hyeon Jin Choi, Kwan Soo Ko
  • Mechanisms of Resistance
    Novobiocin Inhibits the Antimicrobial Resistance Acquired through DNA Damage-Induced Mutagenesis in Acinetobacter baumannii
    Luis M. Jara, María Pérez-Varela, Jordi Corral, Marta Arch, Pilar Cortés, Germán Bou, Jesús Aranda, Jordi Barbé
  • Mechanisms of Resistance
    Double Copies of blaKPC-3::Tn4401a on an IncX3 Plasmid in Klebsiella pneumoniae Successful Clone ST512 from Italy
    Daniela Fortini, Laura Villa, Claudia Feudi, João Pires, Celestino Bonura, Caterina Mammina, Andrea Endimiani, Alessandra Carattoli
  • Mechanisms of Resistance
    Complete Sequences of IncU Plasmids Harboring Quinolone Resistance Genes qnrS2 and aac(6′)-Ib-cr in Aeromonas spp. from Ornamental Fish
    Hana Dobiasova, Petra Videnska, Monika Dolejska
  • Mechanisms of Resistance
    Characterization of a cfr-Carrying Plasmid from Porcine Escherichia coli That Closely Resembles Plasmid pEA3 from the Plant Pathogen Erwinia amylovora
    Rongmin Zhang, Bin Sun, Yang Wang, Lei Lei, Stefan Schwarz, Congming Wu
  • Mechanisms of Resistance
    Acquired Flucytosine Resistance during Combination Therapy with Caspofungin and Flucytosine for Candida glabrata Cystitis
    Caroline Charlier, Carine El Sissy, Sophie Bachelier-Bassi, Anne Scemla, Gilles Quesne, Emilie Sitterlé, Christophe Legendre, Olivier Lortholary, Marie-Elisabeth Bougnoux
  • Mechanisms of Resistance
    fosI Is a New Integron-Associated Gene Cassette Encoding Reduced Susceptibility to Fosfomycin
    Karla de Oliveira Pelegrino, Juliana Coutinho Campos, Suely Carlos Ferreira Sampaio, Karina Lezirovitz, Bruna Mara Seco, Mayne de Oliveira Pereira, Darlan Augusto da Costa Rocha, Thomas Jové, Antonio Carlos Nicodemo, Jorge Luiz Mello Sampaio
  • Mechanisms of Resistance
    Heterologous Expression and Functional Characterization of the Exogenously Acquired Aminoglycoside Resistance Methyltransferases RmtD, RmtD2, and RmtG
    Laís L. Corrêa, Marta A. Witek, Natalia Zelinskaya, Renata C. Picão, Graeme L. Conn
  • Mechanisms of Resistance
    Genome Analysis of Kingella kingae Strain KWG1 Reveals How a β-Lactamase Gene Inserted in the Chromosome of This Species
    Philippe Bidet, Romain Basmaci, Julien Guglielmini, Catherine Doit, Christelle Jost, André Birgy, Stéphane Bonacorsi
  • Mechanisms of Resistance
    Emergence of Carbapenem-Resistant Serotype K1 Hypervirulent Klebsiella pneumoniae Strains in China
    Rong Zhang, Dachuan Lin, Edward Wai-chi Chan, Danxia Gu, Gong-Xiang Chen, Sheng Chen

Susceptibility

  • Susceptibility
    Microbicides Alter the Expression and Function of RND-Type Efflux Pump AdeABC in Biofilm-Associated Cells of Acinetobacter baumannii Clinical Isolates
    Suvarna Krishnamoorthy, Bhavikkumar P. Shah, Hiu Ham Lee, Luis R. Martinez
  • Susceptibility
    Escherichia coli Overexpressing a Baeyer-Villiger Monooxygenase from Acinetobacter radioresistens Becomes Resistant to Imipenem
    Daniela Minerdi, Ivan Zgrablic, Silvia Castrignanò, Gianluca Catucci, Claudio Medana, Maria Elena Terlizzi, Giorgio Gribaudo, Gianfranco Gilardi, Sheila J. Sadeghi
  • Susceptibility
    In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum
    Francielli P. K. Jesus, Érico S. Loreto, Laerte Ferreiro, Sydney H. Alves, David Driemeier, Suyene O. Souza, Raqueli T. França, Sonia T. A. Lopes, Maiara B. Pilotto, Aline Ludwig, Maria I. Azevedo, Tatiana C. Ribeiro, Juliana S. M. Tondolo, Janio M. Santurio
  • Susceptibility
    Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013
    Hui Zhang, Qiwen Yang, Kang Liao, Yuxing Ni, Yunsong Yu, Bijie Hu, Ziyong Sun, Wenxiang Huang, Yong Wang, Anhua Wu, Xianju Feng, Yanping Luo, Zhidong Hu, Yunzhuo Chu, Shulan Chen, Bin Cao, Jianrong Su, Bingdong Gui, Qiong Duan, Shufang Zhang, Haifeng Shao, Haishen Kong, Robert E. Badal, Yingchun Xu
  • Susceptibility
    In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program
    Douglas J. Biedenbach, Richard A. Alm, Sushmita D. Lahiri, Edina Reiszner, Daryl J. Hoban, Daniel F. Sahm, Samuel K. Bouchillon, Jane E. Ambler
  • Susceptibility
    Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms
    Sarah Kennedy, Trevor Beaudoin, Yvonne C. W. Yau, Emma Caraher, James E. A. Zlosnik, David P. Speert, John J. LiPuma, Elizabeth Tullis, Valerie Waters
  • Open Access
    Susceptibility
    Type III Secretion-Dependent Sensitivity of Escherichia coli O157 to Specific Ketolides
    Romina J. Fernandez-Brando, Nao Yamaguchi, Amin Tahoun, Sean P. McAteer, Trudi Gillespie, Dai Wang, Sally A. Argyle, Marina S. Palermo, David L. Gally
  • Susceptibility
    Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914)
    Xiao-Hong Su, Bao-Xi Wang, Wen-Jing Le, Yu-Rong Liu, Chuan Wan, Sai Li, Richard A. Alm, John P. Mueller, Peter A. Rice
  • Susceptibility
    Effect of High-Dose Antimicrobials on Biofilm Growth of Achromobacter Species Isolated from Cystic Fibrosis Patients
    Sean K. Tom, Yvonne C. W. Yau, Trevor Beaudoin, John J. LiPuma, Valerie Waters
  • Susceptibility
    High Prevalence of Biocide Resistance Determinants in Staphylococcus aureus Isolates from Three African Countries
    Teresa Conceição, Céline Coelho, Hermínia de Lencastre, Marta Aires-de-Sousa
  • Susceptibility
    Azole Resistance in Aspergillus fumigatus Clinical Isolates from an Italian Culture Collection
    Cristina Lazzarini, Maria Carmela Esposto, Anna Prigitano, Massimo Cogliati, Gabriella De Lorenzis, Anna Maria Tortorano
  • Open Access
    Susceptibility
    Susceptibility of Clostridium difficile Isolates of Varying Antimicrobial Resistance Phenotypes to SMT19969 and 11 Comparators
    Jane Freeman, Jonathan Vernon, Richard Vickers, Mark H. Wilcox

Analytical Procedures

  • Analytical Procedures
    Bioassay for Determining Voriconazole Serum Levels in Patients Receiving Combination Therapy with Echinocandins
    Maria Siopi, Efthymios Neroutsos, Kalliopi Zisaki, Maria Gamaletsou, Maria Pirounaki, Panagiotis Tsirigotis, Nikolaos Sipsas, Aristides Dokoumetzidis, Evgenios Goussetis, Loukia Zerva, Georgia Valsami, Joseph Meletiadis

Antiviral Agents

  • Open Access
    Antiviral Agents
    Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
    Laurent Detalle, Thomas Stohr, Concepción Palomo, Pedro A. Piedra, Brian E. Gilbert, Vicente Mas, Andrena Millar, Ultan F. Power, Catelijne Stortelers, Koen Allosery, José A. Melero, Erik Depla
  • Open Access
    Antiviral Agents
    Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir-Ritonavir
    Prajakta S. Badri, Sandeep Dutta, Haoyu Wang, Thomas J. Podsadecki, Akshanth R. Polepally, Amit Khatri, Jiuhong Zha, Yi-Lin Chiu, Walid M. Awni, Rajeev M. Menon
  • Antiviral Agents
    Antiretrovirals, Methamphetamine, and HIV-1 Envelope Protein gp120 Compromise Neuronal Energy Homeostasis in Association with Various Degrees of Synaptic and Neuritic Damage
    Ana B. Sanchez, Giuseppe P. Varano, Cyrus M. de Rozieres, Ricky Maung, Irene C. Catalan, Cari C. Dowling, Natalia E. Sejbuk, Melanie M. Hoefer, Marcus Kaul
  • Antiviral Agents
    Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors
    Emiko Urano, Sherimay D. Ablan, Rebecca Mandt, Gary T. Pauly, Dina M. Sigano, Joel P. Schneider, David E. Martin, Theodore J. Nitz, Carl T. Wild, Eric O. Freed
  • Antiviral Agents
    Modification of the Host Cell Lipid Metabolism Induced by Hypolipidemic Drugs Targeting the Acetyl Coenzyme A Carboxylase Impairs West Nile Virus Replication
    Teresa Merino-Ramos, Ángela Vázquez-Calvo, Josefina Casas, Francisco Sobrino, Juan-Carlos Saiz, Miguel A. Martín-Acebes
  • Antiviral Agents
    Intracellular Activation of Tenofovir Alafenamide and the Effect of Viral and Host Protease Inhibitors
    Gabriel Birkus, Rujuta A. Bam, Madeleine Willkom, Christian R. Frey, Luong Tsai, Kirsten M. Stray, Stephen R. Yant, Tomas Cihlar
  • Antiviral Agents
    No Need for Lopinavir Dose Adjustment during Pregnancy: a Population Pharmacokinetic and Exposure-Response Analysis in Pregnant and Nonpregnant HIV-Infected Subjects
    Ahmed Hamed Salem, Aksana Kaefer Jones, Marilia Santini-Oliveira, Graham P. Taylor, Kristine B. Patterson, Angela M. Nilius, Cheri Enders Klein
  • Antiviral Agents
    Incompatible Natures of the HIV-1 Envelope in Resistance to the CCR5 Antagonist Cenicriviroc and to Neutralizing Antibodies
    Takeo Kuwata, Ikumi Enomoto, Masanori Baba, Shuzo Matsushita
  • Antiviral Agents
    Insights into the Molecular Mechanism of Polymerization and Nucleoside Reverse Transcriptase Inhibitor Incorporation by Human PrimPol
    Andrea C. Mislak, Karen S. Anderson
  • Antiviral Agents
    Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase
    Hong-Tao Xu, Susan P. Colby-Germinario, Said Hassounah, Peter K. Quashie, Yingshan Han, Maureen Oliveira, Brent R. Stranix, Mark A. Wainberg
  • Antiviral Agents
    C5A Protects Macaques from Vaginal Simian-Human Immunodeficiency Virus Challenge
    Ronald S. Veazey, Udayan Chatterji, Michael Bobardt, Kasi E. Russell-Lodrigue, Jian Li, Xiaolei Wang, Philippe A. Gallay

Epidemiology and Surveillance

  • Epidemiology and Surveillance
    Antibiotic Resistance among Clinical Ureaplasma Isolates Recovered from Neonates in England and Wales between 2007 and 2013
    Michael L. Beeton, Victoria J. Chalker, Lucy C. Jones, Nicola C. Maxwell, O. Brad Spiller
  • Epidemiology and Surveillance
    Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection
    Marco Falcone, Alessandro Russo, Federica Iraci, Paolo Carfagna, Paola Goldoni, Vincenzo Vullo, Mario Venditti
  • Epidemiology and Surveillance
    A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical Characteristics
    Ana M. Ocampo, Liang Chen, Astrid V. Cienfuegos, Gustavo Roncancio, Kalyan D. Chavda, Barry N. Kreiswirth, J. Natalia Jiménez
  • Epidemiology and Surveillance
    Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014
    Faezeh Mohammadi, Seyed Jamal Hashemi, Jan Zoll, Willem J. G. Melchers, Haleh Rafati, Parvin Dehghan, Sasan Rezaie, Ali Tolooe, Yalda Tamadon, Henrich A. van der Lee, Paul E. Verweij, Seyedmojtaba Seyedmousavi
  • Epidemiology and Surveillance
    Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027
    Jeffrey T. Wieczorkiewicz, Bert K. Lopansri, Adam Cheknis, James R. Osmolski, David W. Hecht, Dale N. Gerding, Stuart Johnson
  • Epidemiology and Surveillance
    Emergence of Mutations in the K13 Propeller Gene of Plasmodium falciparum Isolates from Dakar, Senegal, in 2013-2014
    Agathe Boussaroque, Bécaye Fall, Marylin Madamet, Cheikhou Camara, Nicolas Benoit, Mansour Fall, Aminata Nakoulima, Pierre Dionne, Kadidiatou Ba Fall, Bakary Diatta, Yaya Diémé, Boubacar Wade, Bruno Pradines

Experimental Therapeutics

  • Open Access
    Experimental Therapeutics
    Biofilms of Pathogenic Nontuberculous Mycobacteria Targeted by New Therapeutic Approaches
    Thet Tun Aung, Joey Kuok Hoong Yam, Shuimu Lin, Shuhaida Mohamed Salleh, Michael Givskov, Shouping Liu, Nyein Chan Lwin, Liang Yang, Roger W. Beuerman
  • Experimental Therapeutics
    Benzo[b]quinolizinium Derivatives Have a Strong Antimalarial Activity and Inhibit Indoleamine Dioxygenase
    Esther Jortzik, Kathleen Zocher, Antje Isernhagen, Boniface M. Mailu, Stefan Rahlfs, Giampietro Viola, Sergio Wittlin, Nicholas H. Hunt, Heiko Ihmels, Katja Becker
  • Experimental Therapeutics
    Molecule Targeting Glucosyltransferase Inhibits Streptococcus mutans Biofilm Formation and Virulence
    Zhi Ren, Tao Cui, Jumei Zeng, Lulu Chen, Wenling Zhang, Xin Xu, Lei Cheng, Mingyun Li, Jiyao Li, Xuedong Zhou, Yuqing Li
  • Experimental Therapeutics
    In Vitro Pharmacodynamics of Human Simulated Exposures of Telavancin against Methicillin-Susceptible and -Resistant Staphylococcus aureus with and without Prior Vancomycin Exposure
    Abrar K. Thabit, David P. Nicolau, Joseph L. Kuti
  • Experimental Therapeutics
    Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis
    Rokeya Tasneen, Fabrice Betoudji, Sandeep Tyagi, Si-Yang Li, Kathy Williams, Paul J. Converse, Véronique Dartois, Tian Yang, Carl M. Mendel, Khisimuzi E. Mdluli, Eric L. Nuermberger
  • Experimental Therapeutics
    In Vivo Synergy of Amphotericin B plus Posaconazole in Murine Aspergillosis
    Adela Martin-Vicente, Javier Capilla, Josep Guarro
  • Experimental Therapeutics
    Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection
    B. Rossi, J. F. Soubirou, F. Chau, L. Massias, S. Dion, R. Lepeule, B. Fantin, A. Lefort
  • Experimental Therapeutics
    Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus
    A. del Río, C. García-de-la-Mària, J. M. Entenza, O. Gasch, Y. Armero, D. Soy, C. A. Mestres, J. M. Pericás, C. Falces, S. Ninot, M. Almela, C. Cervera, J. M. Gatell, A. Moreno, P. Moreillon, F. Marco, J. M. Miró, the Hospital Clinic Experimental Endocarditis Study Group
  • Experimental Therapeutics
    Antimicrobial Peptide CMA3 Derived from the CA-MA Hybrid Peptide: Antibacterial and Anti-inflammatory Activities with Low Cytotoxicity and Mechanism of Action in Escherichia coli
    Jong-kook Lee, Chang Ho Seo, Tudor Luchian, Yoonkyung Park
  • Experimental Therapeutics
    In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms
    Maiken Cavling Arendrup, Rasmus Hare Jensen, Manuel Cuenca-Estrella
  • Experimental Therapeutics
    Inhibition of Calcium-Dependent Protein Kinase 1 (CDPK1) In Vitro by Pyrazolopyrimidine Derivatives Does Not Correlate with Sensitivity of Cryptosporidium parvum Growth in Cell Culture
    Theresa B. Kuhlenschmidt, Florentine U. Rutaganira, Shaojun Long, Keliang Tang, Kevan M. Shokat, Mark S. Kuhlenschmidt, L. David Sibley
  • Experimental Therapeutics
    Characterization of the Antimicrobial Peptide Penisin, a Class Ia Novel Lantibiotic from Paenibacillus sp. Strain A3
    Piyush Baindara, Vasvi Chaudhry, Garima Mittal, Luciano M. Liao, Carolina O. Matos, Neeraj Khatri, Octavio L. Franco, Prabhu B. Patil, Suresh Korpole
  • Experimental Therapeutics
    Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages
    Flavia Sorrentino, Ruben Gonzalez del Rio, Xingji Zheng, Jesus Presa Matilla, Pedro Torres Gomez, Maria Martinez Hoyos, Maria Esther Perez Herran, Alfonso Mendoza Losana, Yossef Av-Gay
  • Experimental Therapeutics
    Efficacy of Extended-Interval Dosing of Micafungin Evaluated Using a Pharmacokinetic/Pharmacodynamic Study with Humanized Doses in Mice
    A. Lepak, K. Marchillo, J. VanHecker, N. Azie, D. Andes

Clinical Therapeutics

  • Clinical Therapeutics
    Large Cohort Study of Central Venous Catheter Thrombosis during Intravenous Antibiotic Therapy
    Stéphanie Guillet, Valérie Zeller, Vincent Dubée, Françoise Ducroquet, Nicole Desplaces, Marie Hélène Horellou, Simon Marmor, Jean Marc Ziza
  • Clinical Therapeutics
    Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome
    Jong Sun Park, Jae-Yeon Lee, Yeon Joo Lee, Se Joong Kim, Young-Jae Cho, Ho Il Yoon, Choon-Taek Lee, Junghan Song, Jae Ho Lee
  • Clinical Therapeutics
    Nonimpact of Decolonization as an Adjunctive Measure to Contact Precautions for the Control of Methicillin-Resistant Staphylococcus aureus Transmission in Acute Care
    Lance R. Peterson, Marc O. Wright, Jennifer L. Beaumont, Vanida Komutanon, Parul A. Patel, Donna M. Schora, Bryan H. Schmitt, Ari Robicsek
  • Clinical Therapeutics
    Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care Unit
    Mohd H. Abdul-Aziz, Azrin N. Abd Rahman, Mohd-Basri Mat-Nor, Helmi Sulaiman, Steven C. Wallis, Jeffrey Lipman, Jason A. Roberts, Christine E. Staatz
  • Clinical Therapeutics
    Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer
    Anne-Marie Chaftari, Ray Hachem, Mary Jordan, Kumait Garoge, Zainab Al Hamal, Aline El Zakhem, George M. Viola, Bruno Granwehr, Victor Mulanovich, Andrew Gagel, Ruth Reitzel, Ammar Yousif, Ying Jiang, Issam Raad
  • Clinical Therapeutics
    Neutropenia Associated with Long-Term Ceftaroline Use
    Katherine W. LaVie, Scott W. Anderson, Hollis R. O'Neal, Todd W. Rice, Tatiana C. Saavedra, Catherine S. O'Neal
  • Clinical Therapeutics
    Treatment Outcomes with Fluoroquinolone-Containing Regimens for Isoniazid-Resistant Pulmonary Tuberculosis
    Hyun Lee, Byeong-Ho Jeong, Hye Yun Park, Kyeongman Jeon, Hee Jae Huh, Nam Yong Lee, Won-Jung Koh
  • Clinical Therapeutics
    An Amphipathic Undecapeptide with All d-Amino Acids Shows Promising Activity against Colistin-Resistant Strains of Acinetobacter baumannii and a Dual Mode of Action
    Alberto Oddo, Thomas T. Thomsen, Susanne Kjelstrup, Ciara Gorey, Henrik Franzyk, Niels Frimodt-Møller, Anders Løbner-Olesen, Paul R. Hansen
  • Clinical Therapeutics
    The Clinically Tested Gardos Channel Inhibitor Senicapoc Exhibits Antimalarial Activity
    Venée N. Tubman, Pedro Mejia, Boris E. Shmukler, Amy K. Bei, Seth L. Alper, James R. Mitchell, Carlo Brugnara, Manoj T. Duraisingh
  • Clinical Therapeutics
    In Vitro Activity of Ceftolozane-Tazobactam against Anaerobic Organisms Identified during the ASPECT-cIAI Study
    Eliana S. Armstrong, David J. Farrell, Melissa Palchak, Judith N. Steenbergen
  • Clinical Therapeutics
    Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
    Jessica B. Cprek, Jason C. Gallagher

Pharmacology

  • Pharmacology
    Validation and Application of a Dried Blood Spot Ceftriaxone Assay
    Madhu Page-Sharp, Troy Nunn, Sam Salman, Brioni R. Moore, Kevin T. Batty, Timothy M. E. Davis, Laurens Manning
  • Pharmacology
    Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection
    Jennifer Hoover, Thomas Lewandowski, Robert J. Straub, Steven J. Novick, Peter DeMarsh, Kelly Aubart, Stephen Rittenhouse, Magdalena Zalacain
  • Pharmacology
    Pharmacokinetic-Pharmacodynamic Model for the Effect of l-Arginine on Endothelial Function in Patients with Moderately Severe Falciparum Malaria
    Janneke M. Brussee, Tsin W. Yeo, Daniel A. Lampah, Nicholas M. Anstey, Stephen B. Duffull
  • Pharmacology
    Pharmacodynamics of Isavuconazole in a Dynamic In Vitro Model of Invasive Pulmonary Aspergillosis
    Helen Box, Joanne Livermore, Adam Johnson, Laura McEntee, Timothy W. Felton, Sarah Whalley, Joanne Goodwin, William W. Hope
  • Pharmacology
    Pharmacodynamics of Ceftazidime and Avibactam in Neutropenic Mice with Thigh or Lung Infection
    Johanna Berkhout, Maria J. Melchers, Anita C. van Mil, Seyedmojtaba Seyedmousavi, Claudia M. Lagarde, Virna J. Schuck, Wright W. Nichols, Johan W. Mouton
  • Pharmacology
    Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis
    Ying Jiao Zhao, Ai Leng Khoo, Gloria Tan, Monica Teng, Caroline Tee, Ban Hock Tan, Benjamin Ong, Boon Peng Lim, Louis Yi Ann Chai
  • Pharmacology
    Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli
    Gabrielle A. Gibson, Seth R. Bauer, Elizabeth A. Neuner, Stephanie N. Bass, Simon W. Lam
  • Pharmacology
    Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic Extraction
    Maxwell T. Chirehwa, Roxana Rustomjee, Thuli Mthiyane, Philip Onyebujoh, Peter Smith, Helen McIlleron, Paolo Denti
  • Pharmacology
    Pharmacodynamics of Ceftolozane plus Tazobactam Studied in an In Vitro Pharmacokinetic Model of Infection
    Alasdair P. MacGowan, Alan R. Noel, Sharon G. Tomaselli, Donna Nicholls, Karen E. Bowker
  • Pharmacology
    Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children
    Kristen Nichols, Eun Kyoung Chung, Chad A. Knoderer, Lauren E. Buenger, Daniel P. Healy, Jennifer Dees, Ashley S. Crumby, Michael B. Kays
  • Pharmacology
    Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis
    Stefanie Hennig, Suhashni Naiker, Tarylee Reddy, Deirdre Egan, Tracy Kellerman, Lubbe Wiesner, Andrew Owen, Helen McIlleron, Alexander Pym
  • Pharmacology
    Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in Mice
    Peter Seiler, Michel Enderlin-Paput, Philippe Pfaff, Maria Weiss, Daniel Ritz, Martine Clozel, Hans H. Locher

Letter to the Editor

  • Letter to the Editor
    Effect of Meropenem Concentration on the Detection of Low Numbers of Carbapenem-Resistant Enterobacteriaceae
    Windy D. Tanner, Robyn M. Atkinson, Ramesh K. Goel, Christina A. Porucznik, Lowell Scott Benson, James A. VanDerslice

Errata

  • Free
    Errata
    Erratum for Bueno et al., Coproduction of 16S rRNA Methyltransferase RmtD or RmtG with KPC-2 and CTX-M Group Extended-Spectrum β-Lactamases in Klebsiella pneumoniae
    Maria Fernanda C. Bueno, Gabriela R. Francisco, Jessica A. O'Hara, Doroti de Oliveira Garcia, Yohei Doi
  • Free
    Errata
    Erratum for Antonov et al., “Erratum for Antonov et al., High Prevalence of Pupirocin Resistance in Staphylococcus aureus Isolates from a Pediatric Population”
    Nina K. Antonov, Maria C. Garzon, Kimberly D. Morel, Susan Whittier, Paul J. Planet, Christine T. Lauren

Masthead

  • Free
    Masthead
    Editorial Board
PreviousNext
Back to top

Antimicrobial Agents and Chemotherapy: 60 (1)

In This Issue

volume 60, issue 1
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • Challenging Clinical Cases in Antimicrobial Resistance
  • Chemistry; Biosynthesis
  • Mechanisms of Action: Physiological Effects
  • Mechanisms of Resistance
  • Susceptibility
  • Analytical Procedures
  • Antiviral Agents
  • Epidemiology and Surveillance
  • Experimental Therapeutics
  • Clinical Therapeutics
  • Pharmacology
  • Letter to the Editor
  • Errata
  • Masthead
  • Most Read
  • Most Cited
Loading
  • Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity Against SARS-CoV-2
  • Mechanism-of-Action Classification of Antibiotics by Global Transcriptome Profiling
  • Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions
  • Povidone Iodine: Properties, Mechanisms of Action, and Role in Infection Control and Staphylococcus aureus Decolonization
More...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596